# C. H. Robinson Worldwide, Inc.: financial statements, quarterly

CHRW · Nasdaq · CIK 1043277 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chrw.md) · [Financials](/companies/chrw/financials.md) · [Filings](/companies/chrw/filings.md) · [Insiders](/companies/chrw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chrw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,341](/filings/0001043277-24-000051.md) | [4,222 d](/filings/0001043277-26-000009.md) | [4,412](/filings/0001043277-25-000022.md) | [4,483](/filings/0001043277-25-000037.md) | [4,645](/filings/0001043277-25-000052.md) | [4,185 d](/filings/0001043277-26-000009.md) | [4,047](/filings/0001043277-26-000016.md) | [4,137](/filings/0001043277-26-000031.md) | [4,137](/filings/0001043277-25-000052.md) | [3,913 d](/filings/0001043277-26-000009.md) | [4,013](/filings/0001043277-26-000016.md) | [4,934](/filings/0001043277-26-000031.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [114](/filings/0001043277-24-000051.md) | [107 d](/filings/0001043277-26-000009.md) | [127](/filings/0001043277-25-000022.md) | [178](/filings/0001043277-25-000037.md) | [180](/filings/0001043277-25-000052.md) | [184 d](/filings/0001043277-26-000009.md) | [177](/filings/0001043277-26-000016.md) | [216](/filings/0001043277-26-000031.md) | [221](/filings/0001043277-25-000052.md) | [181 d](/filings/0001043277-26-000009.md) | [176](/filings/0001043277-26-000016.md) | [256](/filings/0001043277-26-000031.md) |
| Income tax | $m | [10.8](/filings/0001043277-24-000051.md) | [38.3 d](/filings/0001043277-26-000009.md) | [17.4](/filings/0001043277-25-000022.md) | [30.3](/filings/0001043277-25-000037.md) | [46.6](/filings/0001043277-25-000052.md) | [19.1 d](/filings/0001043277-26-000009.md) | [21.5](/filings/0001043277-26-000016.md) | [41.4](/filings/0001043277-26-000031.md) | [42.2](/filings/0001043277-25-000052.md) | [30.2 d](/filings/0001043277-26-000009.md) | [19.4](/filings/0001043277-26-000016.md) | [51.1](/filings/0001043277-26-000031.md) |
| Net income | $m | [81.9](/filings/0001043277-24-000051.md) | [31.0 d](/filings/0001043277-26-000009.md) | [92.9](/filings/0001043277-25-000052.md) | [126](/filings/0001043277-25-000052.md) | [97.2](/filings/0001043277-25-000052.md) | [149 d](/filings/0001043277-26-000009.md) | [135](/filings/0001043277-26-000031.md) | [152](/filings/0001043277-26-000031.md) | [163](/filings/0001043277-25-000052.md) | [136 d](/filings/0001043277-26-000009.md) | [147](/filings/0001043277-26-000031.md) | [187](/filings/0001043277-26-000031.md) |
| Diluted EPS | $ per share | [0.68](/filings/0001043277-24-000051.md) | not reported | [0.78](/filings/0001043277-25-000022.md) | [1.05](/filings/0001043277-25-000037.md) | [0.80](/filings/0001043277-25-000052.md) | not reported | [1.11](/filings/0001043277-26-000016.md) | [1.26](/filings/0001043277-26-000031.md) | [1.34](/filings/0001043277-25-000052.md) | not reported | [1.22](/filings/0001043277-26-000016.md) | [1.56](/filings/0001043277-26-000031.md) |
| Basic EPS | $ per share | [0.69](/filings/0001043277-24-000051.md) | not reported | [0.78](/filings/0001043277-25-000022.md) | [1.06](/filings/0001043277-25-000037.md) | [0.81](/filings/0001043277-25-000052.md) | not reported | [1.12](/filings/0001043277-26-000016.md) | [1.27](/filings/0001043277-26-000031.md) | [1.36](/filings/0001043277-25-000052.md) | not reported | [1.23](/filings/0001043277-26-000016.md) | [1.58](/filings/0001043277-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [175](/filings/0001043277-23-000036.md) | [146](/filings/0001043277-25-000012.md) | [122](/filings/0001043277-24-000026.md) | [113](/filings/0001043277-24-000042.md) | [132](/filings/0001043277-24-000051.md) | [146](/filings/0001043277-26-000009.md) | [130](/filings/0001043277-25-000022.md) | [156](/filings/0001043277-25-000037.md) | [137](/filings/0001043277-25-000052.md) | [161](/filings/0001043277-26-000031.md) | [160](/filings/0001043277-26-000016.md) | [155](/filings/0001043277-26-000031.md) |
| Current assets | $m | [2,959](/filings/0001043277-23-000036.md) | [2,881](/filings/0001043277-25-000012.md) | [3,124](/filings/0001043277-24-000026.md) | [3,179](/filings/0001043277-24-000042.md) | [3,339](/filings/0001043277-24-000051.md) | [2,970](/filings/0001043277-26-000009.md) | [2,924](/filings/0001043277-25-000022.md) | [3,014](/filings/0001043277-25-000037.md) | [2,986](/filings/0001043277-25-000052.md) | [2,799](/filings/0001043277-26-000031.md) | [3,007](/filings/0001043277-26-000016.md) | [3,561](/filings/0001043277-26-000031.md) |
| Total assets | $m | [5,318](/filings/0001043277-24-000051.md) | [5,225](/filings/0001043277-26-000009.md) | [5,472](/filings/0001043277-25-000022.md) | [5,512](/filings/0001043277-25-000037.md) | [5,613](/filings/0001043277-25-000052.md) | [5,298](/filings/0001043277-26-000009.md) | [5,226](/filings/0001043277-26-000016.md) | [5,322](/filings/0001043277-26-000031.md) | [5,228](/filings/0001043277-25-000052.md) | [5,058](/filings/0001043277-26-000031.md) | [5,235](/filings/0001043277-26-000016.md) | [5,844](/filings/0001043277-26-000031.md) |
| Current liabilities | $m | [2,650](/filings/0001043277-23-000036.md) | [2,052](/filings/0001043277-25-000012.md) | [2,274](/filings/0001043277-24-000026.md) | [2,244](/filings/0001043277-24-000042.md) | [2,241](/filings/0001043277-24-000051.md) | [2,325](/filings/0001043277-26-000009.md) | [2,263](/filings/0001043277-25-000022.md) | [2,296](/filings/0001043277-25-000037.md) | [1,884](/filings/0001043277-25-000052.md) | [1,832](/filings/0001043277-26-000031.md) | [1,896](/filings/0001043277-26-000016.md) | [2,252](/filings/0001043277-26-000031.md) |
| Total liabilities | $m | [3,913](/filings/0001043277-23-000036.md) | [3,807](/filings/0001043277-25-000012.md) | [4,042](/filings/0001043277-24-000026.md) | [4,002](/filings/0001043277-24-000042.md) | [3,973](/filings/0001043277-24-000051.md) | [3,576](/filings/0001043277-26-000009.md) | [3,491](/filings/0001043277-25-000022.md) | [3,538](/filings/0001043277-25-000037.md) | [3,371](/filings/0001043277-25-000052.md) | [3,213](/filings/0001043277-26-000031.md) | [3,531](/filings/0001043277-26-000016.md) | [4,216](/filings/0001043277-26-000031.md) |
| Long-term debt | $m | [921](/filings/0001043277-23-000036.md) | [1,420](/filings/0001043277-25-000012.md) | [1,421](/filings/0001043277-24-000026.md) | [1,421](/filings/0001043277-24-000042.md) | [1,411](/filings/0001043277-24-000051.md) | [922](/filings/0001043277-26-000009.md) | [922](/filings/0001043277-25-000022.md) | [922](/filings/0001043277-25-000037.md) | [1,183](/filings/0001043277-25-000052.md) | [1,089](/filings/0001043277-26-000031.md) | [1,343](/filings/0001043277-26-000016.md) | [1,685](/filings/0001043277-26-000031.md) |
| Current portion of debt | $m | [663](/filings/0001043277-23-000036.md) | [160](/filings/0001043277-25-000012.md) | [280](/filings/0001043277-24-000026.md) | [188](/filings/0001043277-24-000042.md) | [150](/filings/0001043277-24-000051.md) | [456](/filings/0001043277-26-000009.md) | [468](/filings/0001043277-25-000022.md) | [432](/filings/0001043277-25-000037.md) | [0.0](/filings/0001043277-25-000052.md) | [0.0](/filings/0001043277-26-000016.md) | [0.0](/filings/0001043277-26-000016.md) | not reported |
| Shareholders' equity | $m | [1,405](/filings/0001043277-24-000051.md) | [1,419](/filings/0001043277-26-000009.md) | [1,430](/filings/0001043277-25-000052.md) | [1,510](/filings/0001043277-25-000052.md) | [1,640](/filings/0001043277-25-000052.md) | [1,722](/filings/0001043277-26-000031.md) | [1,735](/filings/0001043277-26-000031.md) | [1,784](/filings/0001043277-26-000031.md) | [1,857](/filings/0001043277-25-000052.md) | [1,846](/filings/0001043277-26-000031.md) | [1,704](/filings/0001043277-26-000031.md) | [1,628](/filings/0001043277-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [205 d](/filings/0001043277-24-000051.md) | [47.3 d](/filings/0001043277-26-000009.md) | [(33.3)](/filings/0001043277-25-000022.md) | [166 d](/filings/0001043277-25-000037.md) | [108 d](/filings/0001043277-25-000052.md) | [268 d](/filings/0001043277-26-000009.md) | [107](/filings/0001043277-26-000016.md) | [227 d](/filings/0001043277-26-000031.md) | [275 d](/filings/0001043277-25-000052.md) | [305 d](/filings/0001043277-26-000009.md) | [68.6](/filings/0001043277-26-000016.md) | [35.9 d](/filings/0001043277-26-000031.md) |
| Capital expenditure | $m | [4.2 d](/filings/0001043277-24-000051.md) | [4.1 d](/filings/0001043277-26-000009.md) | [8.6](/filings/0001043277-25-000022.md) | [6.6 d](/filings/0001043277-25-000037.md) | [4.7 d](/filings/0001043277-25-000052.md) | [2.7 d](/filings/0001043277-26-000009.md) | [3.3](/filings/0001043277-26-000016.md) | [7.3 d](/filings/0001043277-26-000031.md) | [6.0 d](/filings/0001043277-25-000052.md) | [3.0 d](/filings/0001043277-26-000009.md) | [2.6](/filings/0001043277-26-000016.md) | [5.0 d](/filings/0001043277-26-000031.md) |
| Dividends paid | $m | [72.7 d](/filings/0001043277-24-000051.md) | [72.6 d](/filings/0001043277-26-000009.md) | [74.6](/filings/0001043277-25-000022.md) | [72.7 d](/filings/0001043277-25-000037.md) | [73.0 d](/filings/0001043277-25-000052.md) | [74.5 d](/filings/0001043277-26-000009.md) | [77.5](/filings/0001043277-26-000016.md) | [74.9 d](/filings/0001043277-26-000031.md) | [74.7 d](/filings/0001043277-25-000052.md) | [74.3 d](/filings/0001043277-26-000009.md) | [79.0](/filings/0001043277-26-000016.md) | [75.3 d](/filings/0001043277-26-000031.md) |
| Share repurchases | $m | [1.1 d](/filings/0001043277-24-000051.md) | [0.0 d](/filings/0001043277-26-000009.md) | [0.0](/filings/0001043277-25-000022.md) | [0.0 d](/filings/0001043277-25-000037.md) | [0.0 d](/filings/0001043277-25-000052.md) | [0.0 d](/filings/0001043277-26-000009.md) | [47.7](/filings/0001043277-26-000016.md) | [81.1 d](/filings/0001043277-26-000031.md) | [111 d](/filings/0001043277-25-000052.md) | [114 d](/filings/0001043277-26-000009.md) | [213](/filings/0001043277-26-000016.md) | [220 d](/filings/0001043277-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [127](/filings/0001043277-23-000036.md) | [120](/filings/0001043277-24-000026.md) | [120](/filings/0001043277-24-000042.md) | [120](/filings/0001043277-24-000051.md) | [120](/filings/0001043277-25-000022.md) | [120](/filings/0001043277-25-000037.md) | [121](/filings/0001043277-25-000052.md) | [122](/filings/0001043277-26-000016.md) | [121](/filings/0001043277-26-000031.md) | [121](/filings/0001043277-25-000052.md) | [121](/filings/0001043277-26-000016.md) | [120](/filings/0001043277-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,851,258 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001043277-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.